Atlas FDA

Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSF

FDA 510(k) clearance K231348 · decided 2023-06-05

Clearance details

K-number
K231348
Device name
Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSF
Applicant
Roche Diagnostics
Decision
Substantially Equivalent
Date received
2023-05-09
Decision date
2023-06-05
Days to decision
27 days
Clearance type
Traditional
Product code
QSE
Device class
2
Regulation number
866.5840
Medical specialty
Immunology
Advisory committee
Immunology
Location
Indianapolis, IN, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Roche Diagnostics

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF (K221842)Roche Diagnostics2022-12-07
Lumipulse G ß-Amyloid Ratio (1-42/1-40) (DEN200072)Fujirebio Diagnostics,Inc.2022-05-04

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S010)Roche Diagnostics2025-05-22
Elecsys Anti-HBe (P190005/S007)Roche Diagnostics2025-05-22
Elecsys Anti-HBe (P190005/S006)Roche Diagnostics2024-10-03
Elecsys Anti-HBs / Elecsys HBs II (P190034/S009)Roche Diagnostics2024-10-03
Elecsys Anti-HBs II (P190034/S008)Roche Diagnostics2024-08-29
Elecsys Anti-HBe (P190005/S005)Roche Diagnostics2024-08-29
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S007)Roche Diagnostics2024-07-23
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S005)Roche Diagnostics2024-05-01